SFS
MRVI icon

Sowell Financial Services’s Maravai LifeSciences MRVI Stock Holding History

Sowell Financial Services’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25
Closed -$1K – 1893
2021
Q1 		$1K Buy
+25
New +$828 ﹤0.01% 2980

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Sowell Financial Services's MRVI Position: Q2 2021 in Review

Sowell Financial Services sold out of Maravai LifeSciences (MRVI) in Q2 2021, closing a stake of 25 shares — an estimated $1K sold.

Sowell Financial Services first reported a position in MRVI in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 196 funds tracked by Wall St. Rank hold MRVI as of Q2 2021.

  • Sowell Financial Services reported no remaining Maravai LifeSciences position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 25 Maravai LifeSciences shares in Q2 2021, an estimated $1K.
  • Sowell Financial Services first reported a position in Maravai LifeSciences in Q1 2021 and held it in 1 quarter.
  • Sowell Financial Services's Maravai LifeSciences position peaked at $1K in Q1 2021.
  • 196 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.